Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

TG Therapeutics Inc (NASDAQ:TGTX)

7.70
Delayed Data
As of Sep 26
 0.00 / 0.00%
Today’s Change
5.41
Today|||52-Week Range
14.87
-35.46%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2012

2013

2014

2015
AssetsCash0.000.0012.4M55.1M
 
 
 
Short Term Investment Cash6.7M24.0M15.2M-652.5K
 
 
 
 
 
Cash & Short Term Investments16.5M40.5M78.8M77.2M
 
 
 
 
 
 
ReceivablesReceivables0.0027.2K85.5K186.0K
 
 
 
 
 
InventoriesInventories0.00----0.00--
 
Current AssetsPrepaid Expenses2.0M1.7M6.2M9.3M
 
 
 
 
 
Other Current Assets29.1K47.8K174.0K208.3K
 
 
 
 
 
Current Assets18.5M42.3M85.2M86.9M
 
 
 
 
 
 
Total AssetsProperty, Plant and Equipment - Gross--5.7K20.4K--
 
 
 
Intangible Assets3.6M799.4K799.4K799.4K
 
 
 
 
 
Other Assets3.6M884.5K936.5K970.6K
 
 
 
 
 
Total Assets22.1M48.1M86.7M113.5M
 
 
 
 
 
 
LiabilitiesAccounts Payable1.1M4.8M4.0M9.3M
 
 
 
 
 
Short Term Debt677.8K677.8K275.2K211.5K
 
 
 
 
 
Accrued Expenses0.00190.0K0.00--
 
 
Other Current Liabilities275.9K342.4K152.4K152.4K
 
 
 
 
 
Other Liabilities2.2M6.3M5.1M10.5M
 
 
 
 
 
 
Total LiabilitiesLong Term Debt2.5M64.5K0.000.00
 
 
 
Total Liabilities6.5M8.1M6.6M11.9M
 
 
 
 
 
 
EquityMinority Interest-8.1M0.000.000.00
 
 
Preferred Stock0.000.000.000.00--
Common Equity15.6M40.1M80.1M101.6M
 
 
 
 
 
Total Shareholder Equity15.6M40.1M80.1M101.6M
 
 
 
 
 
 
Share InformationCommon Shares Outstanding25.8M34.3M44.9M54.1M
 
 
 
 
 
 
Addtl. Info.No data currently available for this section.